Substantial growth in sales of Tracker kits for routine use: up 18% over first 9 months and up 34% in Q3 Croissy-Beaubourg, October 18, 2018, 6:00pm CEST – THERADIAG (ISIN: FR0004197747, Ticker: ALTER) a company specializing in in…
Croissy-Beaubourg, October 9, 2018, 08:30am CEST – The Board of Directors of THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, announces the departure of Michel Finance, Theradiag’s Chief Executive Officer. He will…
Sharp improvement in operating results Net result close to breakeven Croissy-Beaubourg, September 19, 2018 – 5:45pm CEST - Theradiag (ISIN code: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today released its consolidated…